HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China flag China · Delayed Price · Currency is CNY
10.96
+0.05 (0.46%)
At close: Feb 27, 2026
Market Cap6.33B +51.7%
Revenue (ttm)10.22B -0.3%
Net Income119.14M -53.8%
EPS0.21 -53.7%
Shares Out579.89M
PE Ratio53.10
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,445,500
Average Volume21,586,438
Open10.89
Previous Close10.91
Day's Range10.82 - 10.97
52-Week Range6.40 - 18.13
Beta0.26
RSI42.14
Earnings DateApr 11, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatmen... [Read more]

Sector Healthcare
Founded 1950
Employees 2,870
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600829
Full Company Profile

Financial Performance

In 2024, SHA:600829's revenue was 10.05 billion, a decrease of -3.29% compared to the previous year's 10.39 billion. Earnings were 213.27 million, a decrease of -27.00%.

Financial Statements